Because amyloidosis diagnoses are relatively uncommon, most clinicians have little experience taking care of patients with the disease. Many patients therefore prefer to receive care (or a second-opinion) at an amyloid center (such as Stanford), where patients with the disease are commonly cared for, and a treatment team experienced with the disease is present.
While there is no cure for amyloidosis, treatment therapies can effectively manage amyloid signs and symptoms. Specific treatment options vary based on the type of amyloidosis.
Amyloidosis medication therapy
Using a combination of steroid and chemotherapy drugs.
Chemotherapy and bone marrow transplant in amyloidosis
Strong doses of chemotherapy followed by a bone marrow transplant to restore the body's bone marrow cells.
Do you know if you're at risk for heart disease? How healthy is your heart? In recognition of American Heart Month this February, stay heart healthy and celebrate your heart with us.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
HOW TO REFER
Fax patient records to 650-498-7452. Medical records include:
Recent labs (including but not limited to serum free light chains, SPEP, UPEP)
Pathology reports from all biopsies related to the amyloid diagnosis
Recent clinical notes from any doctor involved with the amyloid diagnosis
Copy of echocardiogram report (if applicable).
For additional questions, please call Trisha Ulloa, RN at 650-725-6186 or email her at firstname.lastname@example.org.